Pfizer Ltd. — Regulatory Filings 2020

Jun 5, 2020

==> picture [63 x 37] intentionally omitted <==

Limited

The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

June 5, 2020

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai - 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Board Meeting to consider Audited Financial Results for the year ended March 31, 2020.

Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 15, 2020, inter alia , to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2020 and to consider recommendation of final dividend, if any, for the Financial Year ended March 31, 2020.

Pursuant to the “Pfizer Limited – Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders”, the Trading Window of the Company was closed from Wednesday, April 1, 2020 till 48 hours after the results are made public on June 15, 2020.

We request you to kindly take the same on record.

Thanking you,

Yours truly, For Pfizer Limited

==> picture [112 x 55] intentionally omitted <==

Prajeet Nair Company Secretary

Cc: National Securities Depository Limited (NSDL) Central Depository Services (India) Limited (CDSL) Kfin Technologies Private Limited

CIN: L24231MH1950PLC008311 contactus.india@pfizer.com